Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Enrofloxacin
Elanco Europe Ltd
QJ01MA90
Enrofloxacin
Oral solution
POM-V - Prescription Only Medicine – Veterinarian
Pigs
Antimicrobial
Authorized
1993-11-11
Revised: September 2023 AN: 03529/2022 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Baytril Piglet Doser 0.5% Oral Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE CONSTITUENTS MG PER ML Enrofloxacin 5.0 RELEVANT CONSTITUENTS OF THE EXCIPIENTS Benzyl Alcohol 14.0 For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral solution. Clear aqueous solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Piglets 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product is for use in the treatment of diseases of the respiratory and alimentary tracts of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis), and multifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice. 4.3 CONTRAINDICATIONS Should not be used for prophylaxis. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known Revised: September 2023 AN: 03529/2022 Page 2 of 5 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond poorly, to other classes of antimicrobials. Whenever possible, fluoroquinolones should only be used based on susceptibility testing. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential for cross resistance. II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS Enrofloxacin may cause hypersensitivity (allergic reactions). People with known hypersensitivity to fluoroquinolone Read the complete document